Montag A & Associates Inc Corcept Therapeutics Inc Transaction History
Montag A & Associates Inc
- $2.09 Billion
- Q3 2024
A detailed history of Montag A & Associates Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Montag A & Associates Inc holds 542 shares of CORT stock, worth $31,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
542
Previous 542
-0.0%
Holding current value
$31,750
Previous $17,000
47.06%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
347Shares Held
86.6MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$969 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$586 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$484 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$381 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$223 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.27B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...